PHYZ Holdings Inc.

TSE:9325.T

891 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Revenue 7,233.056,808.4028,049.2016,667.6386,005.1245,516.9236,782.015,918.5215,447.3085,444.4065,433.0983,592.1023,576.1843,209.5773,656.8873,080.5233,004.2732,874.63,180.1292,552.5482,031.1132,014.8782,371.9062,047.2982,013.9411,900.5572,145.0841,835.8661,546.8261,356.320
Cost of Revenue 6,693.8086,263.7037,294.9796,109.3445,500.3345,036.8116,099.9815,387.0854,930.8564,892.9465,013.9053,418.7623,250.8422,907.5053,283.5842,727.7952,710.572,570.5342,849.222,401.8121,936.5821,857.9132,239.5171,881.8871,824.951,753.3561,910.7341,649.0951,387.4521,224.3580
Gross Profit 539.242544.699754.222558.294504.79480.112682.029531.436516.452551.46419.193173.34325.342302.072373.303352.728293.703304.066330.909150.73694.531156.965132.389165.411188.991147.201234.35186.771159.374131.9620
Gross Profit Ratio 0.0750.080.0940.0840.0840.0870.1010.090.0950.1010.0770.0480.0910.0940.1020.1150.0980.1060.1040.0590.0470.0780.0560.0810.0940.0770.1090.1020.1030.0970
Reseach & Development Expenses 0000000000000000000000000000000
General & Administrative Expenses 0196000214000167000126000830000000000000
Selling & Marketing Expenses 073.83900032.375000156.9020004600010000000000000
SG&A 299.849269.839250.407251.233270246.375275.647232.028313.018323.902218.893183.967166.99172210192112841291261280000000000
Other Expenses 0-2.0762.2683.9256.05311.2812.422-3.124.49.7730.329-21.1055.555-8.0950.7581.8830.811-0.0330.8371.110.2530.6050.5621.420.925-0.382-0.0990.3130.132-3.6430
Operating Expenses 299.849269.839250.407251.233270.651246.375275.647232.028313.018323.902218.893183.967166.99211.535210.319191.642112.606147.002129.258126.17128.544118.517139.498118.75479.81960.06468.73263.29166.00779.6020
Operating Income 239.393274.86503.815307.062234.137233.739406.38299.409203.433227.558200.3-10.626158.3590.538162.983161.086181.096157.063201.6524.567-34.01438.448-7.10946.658109.1787.136165.619123.4893.36652.3590
Operating Income Ratio 0.0330.040.0630.0460.0390.0420.060.0510.0370.0420.037-0.0030.0440.0280.0450.0520.060.0550.0630.01-0.0170.019-0.0030.0230.0540.0460.0770.0670.060.0390
Total Other Income Expenses Net 3.36710.579-0.03212.715209.2314.309-6.11247.0092.7251.934-17.2269.416-10.446-2.56812.0827.349-36.4780.743-9.31129.27912.1592.6264.9692.816-0.161-0.3510.087-0.264-8.8760
Income Before Tax 242.76285.439503.783319.777256.386242.969420.689293.297250.442230.283202.234-27.852167.76680.092160.415173.168188.445120.585202.39315.256-4.73550.607-4.48351.627111.98686.975165.268123.56793.10243.4830
Income Before Tax Ratio 0.0340.0420.0630.0480.0430.0440.0620.050.0460.0420.037-0.0080.0470.0250.0440.0560.0630.0420.0640.006-0.0020.025-0.0020.0250.0560.0460.0770.0670.060.0320
Income Tax Expense 89.524102.921166.605103.66278.32460.361143.81598.53988.69767.94281.98-9.12250.1827.95172.53562.34360.03670.68570.5475.551.5513.0410.50821.72841.08627.25960.95646.79132.44220.7870
Net Income 145.399180.159326.105170.914176.805182.164270.834193.804160.83160.806115.268-23.522115.90651.56687.186110.084127.66349.999132.1538.024-6.28537.566-4.99229.970.959.716104.31276.77560.6622.6950
Net Income Ratio 0.020.0260.0410.0260.0290.0330.040.0330.030.030.021-0.0070.0320.0160.0240.0360.0420.0170.0420.003-0.0030.019-0.0020.0150.0350.0310.0490.0420.0390.0170
EPS 13.5516.7930.415.9316.4816.9825.2518.07151510.75-2.1910.814.818.1310.311.94.6612.270.74-0.583.48-0.462.746.795.9110.347.616.012.480
EPS Diluted 13.5316.7630.3515.9116.4516.9525.218.0314.9714.9810.72-2.1910.794.88.1110.2711.864.6412.230.74-0.583.45-0.462.746.545.59.67.065.582.250
EBITDA 290.266324.251506.374311.025241.033245.073409.546296.731208.371237.432200.725-31.731164.83282.504163.744163.431181.908157.033202.48825.723-20.71239.059-6.54748.081110.16687.165165.521123.79593.49844.6450
EBITDA Ratio 0.040.0480.0630.0470.040.0440.060.050.0380.0440.037-0.0090.0460.0260.0450.0530.0610.0550.0640.01-0.010.019-0.0030.0230.0550.0460.0770.0670.060.0330